Citadel Advisors »

Alterity Therapeutics shares owned by Citadel Advisors

Quarter-by-quarter ownership of Alterity Therapeutics (ATHE) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Alterity Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Alterity Therapeutics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alterity Therapeutics by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $84k 22k 3.77
2024-09-30 $15k 12k 1.34
2024-03-31 $38k 18k 2.05

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Tesla Motors Call Option (TSLA)
NVIDIA Corporation Call Option (NVDA)
Apple Call Option (AAPL)
Meta Platforms Cl A Call Option (META)
Microsoft Corporation Call Option (MSFT)
Spdr Gold Tr Gold Shs Call Option (GLD)
Ishares Tr Russell 2000 Etf (IWM)
Amazon Call Option (AMZN)
Strategy Cl A New Call Option (MSTR)
Alphabet Cap Stk Cl A Call Option (GOOGL)
UnitedHealth Call Option (UNH)
Palantir Technologies Cl A Call Option (PLTR)
Netflix Call Option (NFLX)

View all positions for Citadel Advisors

Top funds holding Alterity Therapeutics

Twin Lakes Capital Management
HB Wealth Management
Greenleaf Trust
Citadel Advisors
Bnp Paribas Arbitrage, Snc
Acadian Asset Management
Rhumbline Advisers
GAMMA Investing
Advisor Group Holdings
EverSource Wealth Advisors
Ronald Blue Trust
Farther Finance Advisors
CoreCap Advisors
Steward Partners Investment Advisory
SBI Securities

View all funds holding Alterity Therapeutics